SeaStar Medical Holding Income from Continuous Operations 2021-2025 | ICU
SeaStar Medical Holding income from continuous operations from 2021 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| SeaStar Medical Holding Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-25 |
| 2023 | $-26 |
| 2022 | $-12 |
| 2021 | $-5 |
| 2020 | $0 |
| SeaStar Medical Holding Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-4 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-4 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-13 |
| 2023-12-31 | $-9 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-7 |
| 2022-12-31 | $-8 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $-1 |
| 2021-12-31 | $-5 |
| 2021-09-30 | $0 |
| 2021-06-30 | $-2 |
| 2021-03-31 | $2 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.007B | $0.000B |
| SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.177B | 26.18 |
| CVS Health (CVS) | United States | $78.558B | 9.80 |
| Elevance Health (ELV) | United States | $63.743B | 8.57 |
| Cencora (COR) | United States | $55.449B | 19.29 |
| DiDi Global (DIDIY) | China | $23.674B | 25.15 |
| Labcorp Holdings (LH) | United States | $21.769B | 17.18 |
| Natera (NTRA) | United States | $18.251B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.562B | 0.00 |
| ICON (ICLR) | Ireland | $13.663B | 13.15 |
| CochLear (CHEOY) | Australia | $13.429B | 0.00 |
| Solventum (SOLV) | United States | $12.346B | 13.07 |
| Medpace Holdings (MEDP) | United States | $12.001B | 31.76 |
| Revvity (RVTY) | United States | $10.361B | 17.98 |
| Viatris (VTRS) | United States | $10.258B | 3.52 |
| Avantor (AVTR) | United States | $9.158B | 13.31 |
| Sonic Healthcare (SKHHY) | Australia | $8.783B | 0.00 |
| HealthEquity (HQY) | United States | $8.388B | 36.74 |
| Charles River Laboratories (CRL) | United States | $8.332B | 16.33 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.144B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.822B | 32.45 |
| Amplifon S.p.A (AMFPF) | Italy | $3.915B | 21.43 |
| BrightSpring Health Services (BTSG) | United States | $3.630B | 33.31 |
| Sotera Health (SHC) | United States | $3.262B | 18.53 |
| GeneDx Holdings (WGS) | United States | $2.909B | 67.07 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.729B | 0.00 |
| Concentras Parent (CON) | United States | $2.560B | 14.79 |
| Organon (OGN) | United States | $2.522B | 2.68 |
| Progyny (PGNY) | United States | $2.015B | 44.36 |
| Premier (PINC) | United States | $1.769B | 13.43 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 34.21 |
| PACS (PACS) | United States | $1.686B | 0.00 |
| Ardent Health (ARDT) | United States | $1.516B | 6.46 |
| Teladoc Health (TDOC) | United States | $1.274B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.052B | 8.01 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.741B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.702B | 6.57 |
| CareDx (CDNA) | United States | $0.684B | 10.68 |
| Embecta (EMBC) | United States | $0.594B | 4.00 |
| LifeMD (LFMD) | United States | $0.473B | 0.00 |
| Nutex Health (NUTX) | United States | $0.471B | 7.13 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| So-Young (SY) | China | $0.451B | 0.00 |
| Omada Health (OMDA) | $0.451B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.449B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.448B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.407B | 0.00 |
| Enhabit (EHAB) | United States | $0.340B | 28.00 |
| Oncology Institute (TOI) | United States | $0.327B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.278B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| Sera Prognostics (SERA) | United States | $0.105B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| KindlyMD (NAKA) | United States | $0.053B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| ModivCare (MODV) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |